跳至主要内容
临床试验/NCT00144898
NCT00144898已完成3 期

A Randomized, Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection (GS) in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 1,627 人开始时间: 2003年7月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
1,627
试验地点
2
主要终点
Survival without recurrence

研究概览

简要总结

Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer.

The GF-GS 01 study, sponsored by a National Hospital Research Program, compares this new surgical method with a classical method in patients having a negative sentinel node.

The duration of the follow-up is 5 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women older than 18 years with clinically node-negative operable unifocal N0 breast cancer (clinical tumour size < 30 mm).
  • Written consent is obtained from all patients before randomization.

排除标准

  • 未提供

研究组 & 干预措施

Sentinel Node Resection

Experimental

Sentinel Node Resection

干预措施: Sentinel Node Resection (Procedure)

Conventional Axillary Dissection

Other

Conventional Axillary Dissection

干预措施: Conventional Axillary Dissection (Procedure)

结局指标

主要结局

Survival without recurrence

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验